|
Important inherited hyperlipoproteinemias |
|||
|
Dyslipidemia |
Protein defect |
Elevated lipoproteins |
Major manifestations |
|
Familial chylomicronemia syndrome |
|
|
|
|
Familial hypercholesterolemia (type II A) |
|
|
|
|
Familial dysbetalipoproteinemia |
|
|
|
|
Familial hypertriglyceridemia |
|
|
|
Familial dysbetalipoproteinemia (type III hyperlipoproteinemia) is characterized by xanthomas and premature coronary and peripheral vascular disease. It is an autosomal recessive disorder that is clinically more severe in patients with other conditions affecting lipoprotein metabolism (eg, diabetes, hypothyroidism).
The primary defects in familial dysbetalipoproteinemia are in ApoE3 and ApoE4, apolipoproteins found on the triglyceride-rich lipoproteins (chylomicrons and VLDLs) that are responsible for binding hepatic apolipoprotein receptors. Without ApoE3 and ApoE4, the liver cannot efficiently remove chylomicrons and VLDL remnants from the circulation, causing their accumulation in the blood and resultant elevations in cholesterol and triglyceride levels.